FIBRODYSPLASIA OSSIFICANS PROGRESSIVA: CASE REPORT OF A TERMINAL PATIENT

被引:0
作者
Munoz-Gomez, M. D. M. [1 ]
机构
[1] Hosp Torrecardenas, Rheumatol Dept, Almeria, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P807
引用
收藏
页码:S381 / S381
页数:1
相关论文
共 5 条
[1]  
CONNOR JM, 1982, J MED GENET, V19, P35, DOI 10.1136/jmg.19.1.35
[2]  
Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868
[3]   Is "fibrodysplasia ossificans progressiva" a vascular disease? A groundbreaking pathogenic model [J].
Morales-Piga, Antonio ;
Javier Bachiller-Corral, Francisco ;
Sanchez-Duffhues, Gonzalo .
REUMATOLOGIA CLINICA, 2014, 10 (06) :389-395
[4]  
Pignolo RJ, 2013, PEDIATR ENDOCR REV P, V10, P437
[5]   Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism [J].
Yui, Paul B. ;
Hong, Charles C. ;
Sachidanandan, Chetana ;
Babitt, Jodie L. ;
Deng, Donna Y. ;
Hoyng, Stefan A. ;
Lin, Herbert Y. ;
Bloch, Kenneth D. ;
Peterson, Randall T. .
NATURE CHEMICAL BIOLOGY, 2008, 4 (01) :33-41